AKI Subphenotypes Carry Different Risks for Major Adverse Kidney Events
Identification of AKI subphenotypes and their pathogenesis may lead to individualized therapies to prevent adverse kidney events.
Diagnosis & Disease Information
Benzbromarone vs Allopurinol for Hyperuricemia May Reduce CKD Risk
Benzbromarone, a urate-lowering drug, appeared effective among patients with high serum uric acid levels who had no evidence of gout flares.
Febuxostat Reduces Contrast-Induced Acute Kidney Injury in Stage 3 CKD
Patients with stage 3 chronic kidney disease are at increased risk for contrast-induced acute kidney injury.
Inequalities in Human Resources for Health Linked to Mortality
Negative association seen between total human resources for health level and all-cause mortality
Sodium Thiosulfate Does Not Improve Calciphylaxis in Chronic Kidney Disease
Currently, there is no approved therapy for calciphylaxis.
Health Care Workers Lack Advance Care Planning Training for CKD Patients
Less than half of providers in Denmark say advance care planning is performed well at their workplace
Dapagliflozin Reduces Serum Uric Acid in Advanced Chronic Kidney Disease
The effects of SGLT2 inhibitors on serum uric acid do not appear to depend on kidney function or diabetes status.
The Changing Treatment Paradigm for IgAN
Clinicians have a growing number of options for treating immunoglobulin A nephropathy.
Rates of Hyperkalemia, Other Adverse Events Increase as CKD Progresses
Adverse events rates have been rising over time among patients receiving dialysis, investigators reported.
Uric Acid Thresholds That Predict Risk of Kidney Failure, Death Identified
The relationship between current serum uric acid levels and death followed a U-shape.
- Loading...
Loading...
Next post in Hyperuricemia
Loading... 
Loading...